Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

In Depth Immunologic Studies in Healthy Young Adults Who Receive The Standard Dose Fluzone (15mcgHA/Virus Strain) Trivalent Inactivated Influenza Virus Vaccine

Trial Profile

In Depth Immunologic Studies in Healthy Young Adults Who Receive The Standard Dose Fluzone (15mcgHA/Virus Strain) Trivalent Inactivated Influenza Virus Vaccine

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Aug 2013

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Jan 2008 Status changed from in progress to completed.
    • 13 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top